Signaling from RAS to RAF: The Molecules and Their Mechanisms

被引:6
|
作者
Jeon, Hyesung [1 ,2 ]
Tkacik, Emre [1 ,3 ]
Eck, Michael J. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Harvard Med Sch, Syst Synthet & Quantitat Biol PhD Program, Boston, MA USA
基金
美国国家卫生研究院;
关键词
MAP kinase pathway; RAS/RAF; protein structure; signal transduction; cancer; RASopathies; PROTEIN PHOSPHATASE 2A; NOONAN-LIKE-SYNDROME; KSR-1 GENE ENCODES; B-RAF; C-RAF; CRYSTAL-STRUCTURE; KINASE-ACTIVITY; MEK INHIBITION; TARGETING RAF; WILD-TYPE;
D O I
10.1146/annurev-biochem-052521-040754
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RAF family protein kinases are a key node in the RAS/RAF/MAP kinase pathway, the signaling cascade that controls cellular proliferation, differentiation, and survival in response to engagement of growth factor receptors on the cell surface. Over the past few years, structural and biochemical studies have provided new understanding of RAF autoregulation,RAF activation by RAS and the SHOC2 phosphatase complex, and RAF engagement with HSP90-CDC37 chaperone complexes. These studies have important implications for pharmacologic targeting of the pathway. They reveal RAF in distinct regulatory states and show that the functional RAF switch is an integrated complex of RAF with its substrate (MEK) and a 14-3-3 dimer. Here we review these advances, placing them in the context of decades of investigation of RAF regulation. We explore the insights they provide into aberrant activation of the pathway in cancer and RASopathies (developmental syndromes caused by germline mutations in components of the pathway).
引用
收藏
页码:289 / 316
页数:28
相关论文
共 50 条
  • [31] RAS signaling in colorectal carcinomas through alterations of RAS, RAF, NF1, and/or RASSF1A
    Ahlquist, Terje
    Bottillo, Irene
    Danielsen, Stine A.
    Meling, Gunn I.
    Rognum, Torleiv O.
    Lind, Guro E.
    Dallapiccola, Bruno
    Lothe, Ragnhild A.
    NEOPLASIA, 2008, 10 (07): : 680 - U3
  • [32] Unfarnesylated transforming Ras mutant inhibits the Ras-signaling pathway by forming a stable Ras center dot Raf complex in the cytosol
    Miyake, M
    Mizutani, S
    Koide, H
    Kaziro, Y
    FEBS LETTERS, 1996, 378 (01) : 15 - 18
  • [33] RAF, RAS and mismatch repair
    Weitzman J.B.
    Genome Biology, 3 (1)
  • [34] The Ras/Raf/MAPK pathway
    Molina, Julian R.
    Adjei, Alex A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (01) : 7 - 9
  • [35] Raf promotes Ras dimerization
    Packer, Morgan
    Parker, Jillian
    Chung, Jean
    Li, Zhenlu
    Lee, Young
    Cookis, Trinity
    Guterres, Hugo
    Alvarez, Steven
    Hossain, M. D.
    Donnelly, Daniel
    Agar, Jeffrey
    Makowski, Lee
    Buck, Matthias
    Groves, Jay
    PROTEIN SCIENCE, 2021, 30 : 132 - 132
  • [36] RAF restrained and ready for RAS
    Eck, Michael
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : A220 - A220
  • [37] Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma
    Favre, Gilles
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 321 - 336
  • [38] Expression and clinical significance of the RAS/RAF/MAPK cell signaling pathway in gastric cancer
    Shen, Bo
    Li, Ming
    Wang, Hongkang
    Xin, Liang
    Xie, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 11682 - 11689
  • [39] The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
    Li, Lei
    Zhao, Guo-Dong
    Shi, Zhe
    Qi, Li-Li
    Zhou, Li-Yuan
    Fu, Ze-Xian
    ONCOLOGY LETTERS, 2016, 12 (05) : 3045 - 3050
  • [40] Mutational status in Ras/Raf/MAPK signaling pathway in Moroccan colorectal cancer patients
    Sqalli Houssaini, M.
    Damou, M.
    Guessous, F.
    Ismaili, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S206 - S206